An office-led valuation decline has pushed Life Science REIT into a loss in its half-year results. The company posted a £13m loss over the six months to 30 June, compared with a £5.4m profit a year earlier, despite a rise
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
